Seven minutes. That’s how long you’d have to pitch your cryptocurrency idea to actor Andrew Duplessie, an angel investor in the space.
Then he’d grill you for seven more minutes to make sure you know what you’re talking about and that you’re not just jumping on the bandwagon.
“[There] are a lot of people trying to take advantage of the bubble,” said Duplessie during a sit-down interview with Cheddar.
Duplessie believes the cryptocurrency industry will continue to evolve from being dominated by programmers into a hub for visionaries.
“We’re seeing more legit entrepreneurs that really think about consumers,” he said. “[They] may not be able to code, but they have a really great vision for user interface and design.”
He also says start-ups that have already secured Series A or Series B funding are “considering ICOs” in the future.
“It only adds a greater value to the entire movement,” Duplessie said.
For full interview, [click here](https://cheddar.com/videos/actor-andrew-duplessie-on-investing-in-crypto).
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
The Federal Reserve kept its key interest rate unchanged Wednesday for a third straight time, and its officials signaled that they expect to make three quarter-point cuts to their benchmark rate next year.
Eliott Wellenbach, vice president and institutional ETF strategist with Direxion, joined Cheddar News to discuss what traders are expecting from consumer spending ahead of the holidays and how they're positioning themselves following the latest inflation data and mortgage rates.
